| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/30/2013 | CN102898271A Synthesis method and use of polycyclic aromatic hydrocarbon and its derivatives |
| 01/30/2013 | CN102898264A Catalytic preparation process for aromatic nitrile or heteroaromatic nitrile |
| 01/30/2013 | CN101801930B 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones |
| 01/30/2013 | CN101528681B New sulfonamide derivatives as bradykinin antagonists |
| 01/30/2013 | CN101503388B Preparation of 1,2,4-tetra (4-pyridinyl) cyclobutane |
| 01/29/2013 | US8362305 Series of skin whitening (lightening) compounds |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362263 Crystalline S-(−)-amlodipine adipic acid salt anhydrous and preparation method thereof |
| 01/29/2013 | US8362256 Salts of N-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamide |
| 01/29/2013 | US8362043 Use in controlling apoptosis, as antiinflammatory agents, in treating autoimmune disease, as antiischemic agents, in treating cardiovascular disorders; for example, 3(R,S)-[2(S)-(3-Benzoylamino-2-oxo-2H-pyridin-1-yl)-3-phenyl-propionylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/29/2013 | US8362017 N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening |
| 01/29/2013 | CA2583918C Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 01/29/2013 | CA2569459C Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/24/2013 | US20130023664 Nitrogen-containing heterocyclic compound and method for producing same |
| 01/24/2013 | US20130023663 Substituted stilbenes and their reactions |
| 01/24/2013 | US20130023661 Fluorinating reagents with (perfluoralkyl) fluorophosphate anion |
| 01/24/2013 | US20130023567 Novel Compounds |
| 01/24/2013 | US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 01/24/2013 | US20130023463 Hiv protease inhibiting compounds |
| 01/23/2013 | EP2548868A1 Method and process for preparation and production of deuterated -diphenylurea |
| 01/23/2013 | EP2548867A1 Method for preparing deuterated diphenylurea |
| 01/23/2013 | EP2548618A2 Organic compounds |
| 01/23/2013 | EP2547656A1 Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | CN202682847U Device capable of realizing biphase continuous separation of nicotinamide |
| 01/23/2013 | CN102892860A Synthesis of four coordinated gold complexes and their applications in light emitting devices thereof |
| 01/23/2013 | CN102892758A Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | CN102892757A Phenol derivatives and the pharmaceutical or cosmetic use thereof |
| 01/23/2013 | CN102892756A Novel amides as fungicides |
| 01/23/2013 | CN102892755A Therapeutic compounds |
| 01/23/2013 | CN102892290A Noxious organism control agent |
| 01/23/2013 | CN102887855A Pyridine-ion-containing liquid, preparation method and application thereof |
| 01/23/2013 | CN102887828A Alcohol-soluble star fluorene material and application thereof |
| 01/23/2013 | CN102020607B 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 01/23/2013 | CN101935299B Organic electron transport and/or cavitation block material and synthesis method and application thereof |
| 01/22/2013 | US8357808 Process for producing diamine derivative |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/22/2013 | CA2532100C 6-(1,1-difluoroalkyl)-4-aminopicolinates and their use as herbicides |
| 01/22/2013 | CA2416307C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 01/22/2013 | CA2382779C Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
| 01/17/2013 | WO2013008256A1 One pot acylation of aromatic amines |
| 01/17/2013 | WO2013007959A1 Novel imaging agents, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/17/2013 | WO2013007621A1 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/17/2013 | WO2013006971A1 Sulfur-containing compounds as anti-proliferative agents |
| 01/17/2013 | WO2012122165A3 Substituted n-aryl pyridinones |
| 01/17/2013 | US20130018193 Deuterated pirfenidone |
| 01/17/2013 | US20130018077 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| 01/17/2013 | US20130018075 Heterocyclic inhibitors of mek and methods of use thereof |
| 01/17/2013 | US20130018054 New compounds |
| 01/17/2013 | CA2837529A1 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/16/2013 | EP2546236A1 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
| 01/16/2013 | EP2546235A1 PROCESS FOR PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS |
| 01/16/2013 | EP2546232A1 Diphenyl Substituted Alkanes |
| 01/16/2013 | EP2545037A1 Inhibitors of protein kinases |
| 01/16/2013 | EP2545036A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 01/16/2013 | CN102884049A Heterocyclic amides as ROCK inhibitors |
| 01/16/2013 | CN102884048A Amino-heteroaryl derivatives as HCN blockers |
| 01/16/2013 | CN102884047A 2-pyridone compounds |
| 01/16/2013 | CN102883783A Treatment agent for decomposition of chemical substance which comprises persulfuric acid salt and silver complex, and method for decomposition of chemical substance using same |
| 01/16/2013 | CN102876319A Spirofluorene pyridine fluorescent material and preparation method thereof |
| 01/16/2013 | CN102875463A Synthesis method for high-quality and low-cost bispyrithione |
| 01/16/2013 | CN102875462A Anti-tumor 2-amino nicotinonitrile, application and preparation method thereof |
| 01/16/2013 | CN102875461A Production method of 4-chloro-2-cyanopyridine |
| 01/16/2013 | CN102875460A Method for preparing sorafenib |
| 01/16/2013 | CN102875459A Synthetic method of 6-acetyl-2-pyridine formic ester |
| 01/16/2013 | CN102875458A Synthesis method of chromium 2-pyridylformate |
| 01/16/2013 | CN102875457A Preparation method of medicine Roflumilast for treating respiratory disease and key intermediate thereof |
| 01/16/2013 | CN102875456A Chemical synthesis method of 3, 6-dichloro-2-aminopyridine |
| 01/16/2013 | CN102875455A Synthesis process of 3, 6-dichloro-2-aminopyridine |
| 01/16/2013 | CN102875454A 2-chloro-5-tirfluoromethylpyridine and synthetic method thereof |
| 01/16/2013 | CN102875453A Preparation method for pyridine medical intermediate for synthesizing anti-cancer auxiliary medicines |
| 01/16/2013 | CN102875452A Chemical synthesis method of 2- (2'-pyridyl) cyclopropanecarboxylic acid derivatives |
| 01/16/2013 | CN102875413A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 01/16/2013 | CN102875276A Method for preparing cyan aromatic hydrocarbon by using aryl bromide |
| 01/16/2013 | CN102875273A Synthetic method of heteroaryl ether |
| 01/16/2013 | CN101812016B Method for preparing 6-methylnicotinic acid etoricoxib intermediate and ester thereof |
| 01/16/2013 | CN101534644B Process for preparing pyridinamines and novel polymorphs thereof |
| 01/16/2013 | CN101508649B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/15/2013 | US8354402 Polyarylcarboxamides useful as lipid lowering agents |
| 01/10/2013 | WO2013006738A1 Compounds for the treatment of hiv |
| 01/10/2013 | WO2013006400A1 Compounds for the treatment of addiction |
| 01/10/2013 | WO2013004996A1 5- or 6 - substituted 3 - hydroxy - 2 ( 1h) - pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain |
| 01/10/2013 | WO2012138172A3 Novel organometallic compound, and organic light-emitting diode using same |
| 01/10/2013 | US20130012716 Substituted acetophenones useful as pde4 inhibitors |
| 01/10/2013 | US20130012713 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
| 01/10/2013 | US20130012548 Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising the compounds |
| 01/10/2013 | US20130012541 Therapeutic Agents Useful for Treating Pain |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130012487 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors |
| 01/10/2013 | US20130009142 Charge transport compositions and electronic devices made with such compositions |
| 01/10/2013 | CA2840763A1 Compounds for the treatment of addiction |
| 01/10/2013 | CA2840095A1 Compounds for the treatment of hiv |
| 01/09/2013 | EP2543658A1 Method for producing a-acyloxycarbonyl compound and novel a-acyloxycarbonyl compound |
| 01/09/2013 | EP2542529A1 Urethanes, ureas, amidines and related inhibitors of factor xa |
| 01/09/2013 | EP2542528A1 Heterocyclic amides as rock inhibitors |
| 01/09/2013 | EP2542527A2 Process for the preparation of atazanavir sulfate substantially free of diastereomers |
| 01/09/2013 | EP2542086A1 Compounds and therapeutic uses thereof |
| 01/09/2013 | EP2542077A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/09/2013 | CN102869729A Metal complex dye, photoelectric conversion element, and dye-sensitized solar cell |
| 01/09/2013 | CN102869636A Novel organic compound and organic light-emitting device including the same |
| 01/09/2013 | CN102863432A Modulators of cftr |